ChemoCentryx, Inc.
CCXI
CCXI was delisted on the 19th of October, 2022.
70 hedge funds and large institutions have $216M invested in ChemoCentryx, Inc. in 2015 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 27 increasing their positions, 22 reducing their positions, and 7 closing their positions.
23% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 22
8% more capital invested
Capital invested by funds: $200M → $216M (+$15.8M)
6% more call options, than puts
Call options by funds: $721K | Put options by funds: $680K
0% more funds holding
Funds holding: 70 → 70 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
+$3.64M |
| 2 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$3.42M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
+$3M |
| 4 |
A
Abingworth
London,
United Kingdom
|
+$837K |
| 5 |
AG
Artal Group
Luxembourg
|
+$794K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$8.21M |
| 2 |
ACA
Avoro Capital Advisors
New York
|
-$2.44M |
| 3 |
First Manhattan
New York
|
-$1.97M |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
-$1.17M |
| 5 |
BACM
Blue Arrow Capital Management
New York
|
-$941K |
CCXI Hedge Fund Activity: Q2 2015 in Review
70 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q2 2015, worth a combined $216M — up 7.9% from $200M a quarter earlier.
Fund positioning in CCXI was balanced in Q2 2015: 7 funds opened new positions, 7 closed out, 27 added to existing stakes and 22 trimmed.
The largest buyer was Redmile Group, adding an estimated $3.64M. The largest seller was BVF Inc, cutting an estimated $8.21M.
- 70 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q2 2015, unchanged from Q1 2015.
- Funds reported $216M of ChemoCentryx, Inc. stock for Q2 2015, up 7.9% quarter-over-quarter.
- 7 funds opened new ChemoCentryx, Inc. positions in Q2 2015 and 7 closed out, a net change of 0 holders.
- The largest ChemoCentryx, Inc. buyer in Q2 2015 was Redmile Group, an estimated $3.64M added.
- The largest ChemoCentryx, Inc. seller in Q2 2015 was BVF Inc, an estimated $8.21M sold.
Based on aggregated 13F filings for Q2 2015.